Segall Bryant & Hamill LLC Purchases 17,902 Shares of Encompass Health Co. (NYSE:EHC)

Segall Bryant & Hamill LLC boosted its position in shares of Encompass Health Co. (NYSE:EHC) by 12.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 160,137 shares of the company’s stock after buying an additional 17,902 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.16% of Encompass Health worth $15,476,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its holdings in shares of Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after purchasing an additional 26,270 shares during the period. QRG Capital Management Inc. lifted its position in shares of Encompass Health by 85.6% in the 2nd quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after purchasing an additional 6,627 shares during the period. SG Americas Securities LLC bought a new stake in shares of Encompass Health during the 2nd quarter valued at about $2,204,000. Los Angeles Capital Management LLC increased its position in shares of Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares during the period. Finally, Kennedy Capital Management LLC raised its stake in Encompass Health by 19.6% in the first quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company’s stock worth $8,235,000 after buying an additional 16,318 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on EHC shares. Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada raised their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp upped their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group lifted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Finally, Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Down 0.2 %

NYSE:EHC opened at $98.90 on Thursday. The stock has a market cap of $9.96 billion, a price-to-earnings ratio of 23.89, a PEG ratio of 1.31 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company’s 50 day moving average price is $96.83 and its 200-day moving average price is $90.63. Encompass Health Co. has a 52 week low of $63.78 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period last year, the business posted $0.86 EPS. The company’s revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.

Encompass Health declared that its board has authorized a stock repurchase plan on Wednesday, July 24th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to repurchase up to 5.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.